• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE Back to Search Results
Model Number GF-UCT260
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation (2001); Unspecified Hepatic or Biliary Problem (4493)
Event Date 05/18/2022
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.The investigation is ongoing.If additional information becomes available, this report will be supplemented accordingly.
 
Event Description
Olympus reviewed the following literature titled, "long-term outcomes of endoscopic double stenting using an anti-reflux metal stent for combined malignant biliary and duodenal obstruction".Purpose: to evaluate long-term outcomes of endoscopic double stenting using anti-reflux metal stents (arms) for combined malignant biliary and duodenal obstruction.Methods: consecutive patients with advanced pancreatic cancer who received endoscopic double stenting with self-expandable metal stents (sems) for combined malignant biliary and duodenal obstruction at our institution between july 2014 and march 2021 were evaluated.Patients were divided into the arms group, endoscopic ultrasound-guided hepaticogastrostomy (eus-hgs) group, and covered metal stent-transpapillary (cms-transpapillary) group.A duckbilltype metal stent was used in all arms cases.Results: thirty-eight patients were enrolled: arms group (n = 16), eus-hgs group (n = 13), and cms-transpapillary group (n = 9).Overall survival among three groups were not significantly different.Recurrent biliary obstruction (rbo) rates of the arms, eus-hgs, and cms-transpapillary groups were 12.5%, 61.5%, and 88.9% (p<.01) and median time to recurrent biliary obstructions (trbos) were not reached, 125days, and 7days (p<.01).Median trbos of armscholedochoduodenostomy and arms-transpapillary were not statistically different.Major causes of rbo were stent occlusion and symptomatic stent migration in the arms group, hyperplasia in the eus-hgs group, and non-occlusion cholangitis in the cms-transpapillary group.Conclusions: endoscopic double stenting with arms might be an option for combined malignant biliary and duodenal obstruction.Type of adverse events/number of patients perforation(eus-hgs group) n=1 recurrent biliary obstruction n=8 this literature article requires 4 reports.The related patient identifiers are as follows: 1.(b)(6).This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation and to provide additional information received from the author.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Event Description
Additional information received from the author confirmed there was no particular causal relationship between the device and the adverse event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE
Type of Device
ULTRASOUND GASTROVIDEOSCOPE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer (Section G)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16595485
MDR Text Key311827842
Report Number3002808148-2023-02851
Device Sequence Number1
Product Code ODG
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGF-UCT260
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received05/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
NON-OLYMPUS: METAL STENT.
Patient Outcome(s) Other;
-
-